Potentiation of antidepressant effects: NPY1R agonist and ketamine synergy enhances TrkB signaling and neurogenesis in the ventral hippocampus
Sign Up to like & getrecommendations! Published in 2024 at "Expert Opinion on Therapeutic Targets"
DOI: 10.1080/14728222.2024.2342524
Abstract: ABSTRACT Background Major Depressive Disorder (MDD) poses a significant challenge to global health, with current treatments often limited by efficacy and onset delays. This study explores the synergistic antidepressant-like effects of an NPY1R agonist and… read more here.
Keywords: neurogenesis; npy1r agonist; agonist ketamine; ventral hippocampus ... See more keywords